Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial
Irina Khripun, Sergey N. Vorobyev, Igor Belousov, et al.
The Aging Male (2018) Vol. 22, Iss. 4, pp. 241-249
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men
Satılmış Bilgin, Gülali Aktaş, Mehmet Zahid Koçak, et al.
The Aging Male (2019) Vol. 23, Iss. 5, pp. 923-927
Closed Access | Times Cited: 100
Treatment with Testosterone Therapy in Type 2 Diabetic Hypogonadal Adult Males: A Systematic Review and Meta-Analysis
K G Sudha Kumari, Rohan Kumar, Areeba Memon, et al.
Clinics and Practice (2023) Vol. 13, Iss. 2, pp. 454-469
Open Access | Times Cited: 21
Obesity, metabolic dysfunction, and risk of kidney stone disease: a national cross-sectional study
Zhenyang Ye, Changjing Wu, Yang Xiong, et al.
The Aging Male (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 21
Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis
Shuying Li, Yaling Zhao, Yufan Yang, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 41
The Role of testosterone treatment in patients with metabolic disorders
Giovanni Corona, Giulia Rastrelli, Linda Vignozzi, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 9, pp. 1091-1103
Closed Access | Times Cited: 31
Effects of testosterone therapy in adult males with hypogonadism and T2DM: A meta-analysis and systematic review
Satesh Kumar, Mahima Khatri, Rahat A Memon, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 8, pp. 102588-102588
Closed Access | Times Cited: 21
Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome
Geoffrey Hackett
Sexual Medicine Reviews (2019) Vol. 7, Iss. 3, pp. 476-490
Closed Access | Times Cited: 30
Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial)
Kristina Groti Antonič, Blaž Antonič, Ivan Žuran, et al.
The Aging Male (2020) Vol. 23, Iss. 5, pp. 1442-1454
Open Access | Times Cited: 29
EMAS position statement: Testosterone replacement therapy in older men
George Kanakis, Riccardo Pofi, Dimitrios G. Goulis, et al.
Maturitas (2023) Vol. 178, pp. 107854-107854
Open Access | Times Cited: 8
TRACK_9: Testosterone replacement assessment: Classical vs. functional hypogonadism‐knowledge from a 9‐year study
Michael Zitzmann, Jann‐Frederik Cremers, Claudia Krallmann, et al.
Andrology (2024) Vol. 12, Iss. 8, pp. 1675-1696
Open Access | Times Cited: 2
Testosterone deficiency and chronic kidney disease
Michael Zitzmann
Journal of Clinical & Translational Endocrinology (2024) Vol. 37, pp. 100365-100365
Open Access | Times Cited: 2
Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis
Jianzhong Zhang, Xiao Li, Zhonglin Cai, et al.
The Aging Male (2019) Vol. 23, Iss. 5, pp. 607-618
Closed Access | Times Cited: 23
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts
Omer Faruk Kırlangıç, Didem Yilmaz‐Oral, Ecem Kaya‐Sezginer, et al.
Sexual Medicine (2020) Vol. 8, Iss. 2, pp. 132-155
Open Access | Times Cited: 19
The association between metabolic syndrome and benign prostatic hyperplasia: a systematic review and meta-analysis
Jinze Li, Lei Peng, Dehong Cao, et al.
The Aging Male (2020) Vol. 23, Iss. 5, pp. 1388-1399
Open Access | Times Cited: 19
Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort study
Adrian Heald, Ghasem Yadegar far, Mark Livingston, et al.
Cardiovascular Endocrinology & Metabolism (2020) Vol. 10, Iss. 1, pp. 37-44
Open Access | Times Cited: 18
Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
Fnu Deepika, Elliot S. Ballato, Georgia Colleluori, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
Abraham Morgentaler, Sandeep Dhindsa, Adrian S. Dobs, et al.
Mayo Clinic Proceedings (2024) Vol. 99, Iss. 11, pp. 1785-1801
Closed Access | Times Cited: 1
Statins are effective in the treatment of benign prostatic hyperplasia with metabolic syndrome
Süleyman Sami Çakır, Levent Özcan, Emre Can Polat, et al.
The Aging Male (2018) Vol. 23, Iss. 5, pp. 538-543
Closed Access | Times Cited: 14
Serum progesterone and retinopathy in male patients with type 2 diabetes: A cross‐sectional study
Shengnan Sun, Yahao Wang, Yue Zhou, et al.
Journal of Diabetes Investigation (2020) Vol. 12, Iss. 7, pp. 1228-1235
Open Access | Times Cited: 7
Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men
Aino Siltari, Teemu J. Murtola, Josefina Kausz, et al.
Acta Oncologica (2023) Vol. 62, Iss. 12, pp. 1898-1904
Open Access | Times Cited: 2
Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge
Kristina Groti Antonič, Michael Zitzmann
The Aging Male (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 2
Important lessons about testosterone therapy- weight loss vs. testosterone therapy for symptom resolution, classical vs. functional hypogonadism, and shortterm vs. lifelong testosterone therapy
Monica Caliber, Geoff Hackett
The Aging Male (2019) Vol. 23, Iss. 5, pp. 585-591
Closed Access | Times Cited: 6
Systemic effects of the hormonal treatment of male hypogonadism with preliminary indications for the management of COVID-19 patients
Rossella Cannarella, Aldo E. Calogero, Rosita A. Condorelli, et al.
Therapeutic Advances in Endocrinology and Metabolism (2020) Vol. 11
Open Access | Times Cited: 6
Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism
Kristina Groti Antonič
The Aging Male (2022) Vol. 25, Iss. 1, pp. 269-277
Open Access | Times Cited: 4
Type 2 diabetes mellitus is more commonly well controlled in younger men compared to older men
Mehmet Zahid Koçak, Gülali Aktaş, Tuba Taslamacıoğlu Duman, et al.
The Aging Male (2019) Vol. 23, Iss. 5, pp. 906-910
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top